Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Discover yearly leaders among index funds and understand how performance shifts across periods, helping you choose resilient options.
27,236 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Bitcoin trades below $65k, yet Polymarket participants are betting on a $150k price by year-end 2026. This article ex...
Retiring to Cape Coral with a $900,000 portfolio and a waterfront home sounds idyllic, but the true cost includes tax...
Two KKR Co-CEOs bought a combined 175,000 shares in February, signaling confidence as the stock trades in the mid-$90...
Realtor.com’s midyear forecast for 2026 projects slower home price growth and steady mortgage rates, hinting at stron...
Mortgage originations climbed to a three-year peak in Q4 2025, led by a refinancing wave that expanded affordability ...
Jim Cramer advises investors to wait before buying Vertiv after a pronounced dip, arguing that selling pressure could...
A fresh AI-related order sparked a sharp move in Aehr Test Systems stock, with investors pricing in potential growth ...
Large Bitcoin holders are stepping back into accumulation as BTC hovers near $71,000, a move that could signal renewe...
As Lumentum and Coherent rally, Onto Innovation could be the next optics supplier to gain. Analysts say the surge ref...
Korea's top exchanges show XRP eclipsing Bitcoin in 24-hour volume as local retail traders bet on high-volatility coi...
In 1999, Mark Cuban reportedly earned more from hedging Yahoo shares with a protective collar than from selling Broad...